GRDN Valuation

Guardian Pharmacy Services Inc

Add to Watchlist

Advanced Chart

26.290

+0.24(0.921%)1D

Overview
Forecast
Valuation
Earnings

GRDN Relative Valuation

GRDN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, GRDN is overvalued; if below, it's undervalued.

Historical Valuation

Guardian Pharmacy Services Inc (GRDN) is now in the Overvalued zone, suggesting that its current forward PE ratio of 25.61 is considered Overvalued compared with the five-year average of 23.92. The fair price of Guardian Pharmacy Services Inc (GRDN) is between 20.79 to 24.98 according to relative valuation methord. Compared to the current price of 26.05 USD , Guardian Pharmacy Services Inc is Overvalued By 4.28%.

Relative Value

Fair Zone

20.79-24.98

Current Price：26.05

4.28%

Overvalued

26.27

Trailing

Forward

15.66

EV/EBITDA

Guardian Pharmacy Services Inc. (GRDN) has a current EV/EBITDA of 15.66. The 5-year average EV/EBITDA is 14.54. The thresholds are as follows: Strongly Undervalued below 11.93, Undervalued between 11.93 and 13.23, Fairly Valued between 15.84 and 13.23, Overvalued between 15.84 and 17.14, and Strongly Overvalued above 17.14. The current Forward EV/EBITDA of 15.66 falls within the Historic Trend Line -Fairly Valued range.

21.65

EV/EBIT

Guardian Pharmacy Services Inc. (GRDN) has a current EV/EBIT of 21.65. The 5-year average EV/EBIT is 20.44. The thresholds are as follows: Strongly Undervalued below 16.30, Undervalued between 16.30 and 18.37, Fairly Valued between 22.52 and 18.37, Overvalued between 22.52 and 24.59, and Strongly Overvalued above 24.59. The current Forward EV/EBIT of 21.65 falls within the Historic Trend Line -Fairly Valued range.

1.13

Guardian Pharmacy Services Inc. (GRDN) has a current PS of 1.13. The 5-year average PS is 1.02. The thresholds are as follows: Strongly Undervalued below 0.82, Undervalued between 0.82 and 0.92, Fairly Valued between 1.12 and 0.92, Overvalued between 1.12 and 1.21, and Strongly Overvalued above 1.21. The current Forward PS of 1.13 falls within the Overvalued range.

0.00

P/OCF

Guardian Pharmacy Services Inc. (GRDN) has a current P/OCF of 0.00. The 5-year average P/OCF is 12.14. The thresholds are as follows: Strongly Undervalued below -7.34, Undervalued between -7.34 and 2.40, Fairly Valued between 21.88 and 2.40, Overvalued between 21.88 and 31.62, and Strongly Overvalued above 31.62. The current Forward P/OCF of 0.00 falls within the Undervalued range.

0.00

P/FCF

Guardian Pharmacy Services Inc. (GRDN) has a current P/FCF of 0.00. The 5-year average P/FCF is 18.25. The thresholds are as follows: Strongly Undervalued below -8.29, Undervalued between -8.29 and 4.98, Fairly Valued between 31.53 and 4.98, Overvalued between 31.53 and 44.80, and Strongly Overvalued above 44.80. The current Forward P/FCF of 0.00 falls within the Undervalued range.

Guardian Pharmacy Services Inc (GRDN) has a current Price-to-Book (P/B) ratio of 9.48. Compared to its 3-year average P/B ratio of 8.50 , the current P/B ratio is approximately 11.48% higher. Relative to its 5-year average P/B ratio of 8.50, the current P/B ratio is about 11.48% higher. Guardian Pharmacy Services Inc (GRDN) has a Forward Free Cash Flow (FCF) yield of approximately 2.41%. Compared to its 3-year average FCF yield of 3.13%, the current FCF yield is approximately -22.91% lower. Relative to its 5-year average FCF yield of 3.13% , the current FCF yield is about -22.91% lower.

9.72

P/B

Median3y

8.50

Median5y

8.50

2.36

FCF Yield

Median3y

3.13

Median5y

3.13

Competitors Valuation Multiple

The average P/S ratio for GRDN's competitors is 0.48, providing a benchmark for relative valuation. Guardian Pharmacy Services Inc Corp (GRDN) exhibits a P/S ratio of 1.13, which is 138.32% above the industry average. Given its robust revenue growth of 35.86%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

GRDN.N

Guardian Pharmacy Services Inc

Walgreens Boots Alliance Inc

Performance Decomposition

Market capitalization of GRDN increased by 46.79% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -9.64 to -17.77.

The secondary factor is the Revenue Growth, contributed 35.86%to the performance.

Overall, the performance of GRDN in the past 1 year is driven by P/E Change. Which is more unsustainable.

35.86%

253.44M → 344.33M

Revenue Growth

-73.44%

9.64 → 2.56

Margin Expansion

84.37%

-9.64 → -17.77

P/E Change

46.79%